The central clinical idea: when mitochondrial ATP production falls and oxidative stress rises, the brain may lose the energy and antioxidant reserve needed to regulate neurotransmission, maintain cell membranes, recycle methionine, produce SAM, clear adenosine and homocysteine, build glutathione and tolerate medications or supplements
Additionally, increases were noted in other T-cell subsets such as Th1, Th2, and regulatory T cells, changes that may influence vulnerability to infections, allergies, or autoimmune conditions
Patients deserve that clarity before a wellness trend hardens into an assumption
Novo Nordisk is the worlds largest manufacturer of insulin and one of the leading producers of obesity and diabetes medications